Gene-expression profiling of adrenocortical carcinoma

Insoo Suh, Marlon A Guerrero, Electron Kebebew

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. The clinical management of ACC is complicated by the inadequacy of current diagnostic modalities to accurately distinguish benign from malignant adrenocortical tumors. In addition, efforts to better predict clinical tumor behavior are limited by the lack of a better understanding of the molecular mechanisms of adrenocortical carcinogenesis. There have been no significant improvements in the treatment of ACC. Thus, there is a pressing need for the development of new therapeutic approaches for patients with ACC, as most patients present with advanced locoregional and metastatic disease. The prospects of identifying diagnostic and prognostic markers or gene profiles for ACC have significantly improved with the development of genome-wide gene-expression analysis. Since 2003, several studies have reported distinct gene-expression profiles between benign and malignant adrenocortical tumors that may have diagnostic and prognostic clinical utility. In this article, we discuss the limitations of the clinical management of ACC, and the gene-expression profile studies that have attempted to address these limitations.

Original languageEnglish (US)
Pages (from-to)343-351
Number of pages9
JournalExpert Review of Molecular Diagnostics
Volume9
Issue number4
DOIs
StatePublished - May 2009
Externally publishedYes

Fingerprint

Adrenocortical Carcinoma
Gene Expression Profiling
Transcriptome
Neoplasms
Adrenal Cortex
Carcinogenesis
Genome
Gene Expression
Therapeutics
Genes

Keywords

  • Adrenal incidentaloma
  • Adrenalectomy
  • Adrenocortical carcinoma
  • Diagnostic marker
  • Gene-expression profiling
  • Prognostic marker

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

Gene-expression profiling of adrenocortical carcinoma. / Suh, Insoo; Guerrero, Marlon A; Kebebew, Electron.

In: Expert Review of Molecular Diagnostics, Vol. 9, No. 4, 05.2009, p. 343-351.

Research output: Contribution to journalArticle

Suh, Insoo ; Guerrero, Marlon A ; Kebebew, Electron. / Gene-expression profiling of adrenocortical carcinoma. In: Expert Review of Molecular Diagnostics. 2009 ; Vol. 9, No. 4. pp. 343-351.
@article{faa8c41531bb40dcb8247bb99cbeb9be,
title = "Gene-expression profiling of adrenocortical carcinoma",
abstract = "Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. The clinical management of ACC is complicated by the inadequacy of current diagnostic modalities to accurately distinguish benign from malignant adrenocortical tumors. In addition, efforts to better predict clinical tumor behavior are limited by the lack of a better understanding of the molecular mechanisms of adrenocortical carcinogenesis. There have been no significant improvements in the treatment of ACC. Thus, there is a pressing need for the development of new therapeutic approaches for patients with ACC, as most patients present with advanced locoregional and metastatic disease. The prospects of identifying diagnostic and prognostic markers or gene profiles for ACC have significantly improved with the development of genome-wide gene-expression analysis. Since 2003, several studies have reported distinct gene-expression profiles between benign and malignant adrenocortical tumors that may have diagnostic and prognostic clinical utility. In this article, we discuss the limitations of the clinical management of ACC, and the gene-expression profile studies that have attempted to address these limitations.",
keywords = "Adrenal incidentaloma, Adrenalectomy, Adrenocortical carcinoma, Diagnostic marker, Gene-expression profiling, Prognostic marker",
author = "Insoo Suh and Guerrero, {Marlon A} and Electron Kebebew",
year = "2009",
month = "5",
doi = "10.1586/erm.09.13",
language = "English (US)",
volume = "9",
pages = "343--351",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "4",

}

TY - JOUR

T1 - Gene-expression profiling of adrenocortical carcinoma

AU - Suh, Insoo

AU - Guerrero, Marlon A

AU - Kebebew, Electron

PY - 2009/5

Y1 - 2009/5

N2 - Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. The clinical management of ACC is complicated by the inadequacy of current diagnostic modalities to accurately distinguish benign from malignant adrenocortical tumors. In addition, efforts to better predict clinical tumor behavior are limited by the lack of a better understanding of the molecular mechanisms of adrenocortical carcinogenesis. There have been no significant improvements in the treatment of ACC. Thus, there is a pressing need for the development of new therapeutic approaches for patients with ACC, as most patients present with advanced locoregional and metastatic disease. The prospects of identifying diagnostic and prognostic markers or gene profiles for ACC have significantly improved with the development of genome-wide gene-expression analysis. Since 2003, several studies have reported distinct gene-expression profiles between benign and malignant adrenocortical tumors that may have diagnostic and prognostic clinical utility. In this article, we discuss the limitations of the clinical management of ACC, and the gene-expression profile studies that have attempted to address these limitations.

AB - Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. The clinical management of ACC is complicated by the inadequacy of current diagnostic modalities to accurately distinguish benign from malignant adrenocortical tumors. In addition, efforts to better predict clinical tumor behavior are limited by the lack of a better understanding of the molecular mechanisms of adrenocortical carcinogenesis. There have been no significant improvements in the treatment of ACC. Thus, there is a pressing need for the development of new therapeutic approaches for patients with ACC, as most patients present with advanced locoregional and metastatic disease. The prospects of identifying diagnostic and prognostic markers or gene profiles for ACC have significantly improved with the development of genome-wide gene-expression analysis. Since 2003, several studies have reported distinct gene-expression profiles between benign and malignant adrenocortical tumors that may have diagnostic and prognostic clinical utility. In this article, we discuss the limitations of the clinical management of ACC, and the gene-expression profile studies that have attempted to address these limitations.

KW - Adrenal incidentaloma

KW - Adrenalectomy

KW - Adrenocortical carcinoma

KW - Diagnostic marker

KW - Gene-expression profiling

KW - Prognostic marker

UR - http://www.scopus.com/inward/record.url?scp=66449084207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449084207&partnerID=8YFLogxK

U2 - 10.1586/erm.09.13

DO - 10.1586/erm.09.13

M3 - Article

C2 - 19441174

AN - SCOPUS:66449084207

VL - 9

SP - 343

EP - 351

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 4

ER -